Clinical Trials Search Results

Results 1-10 of 346 for your search
Show Search Criteria
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 836 locations
Nivolumab after Combined Modality Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 586 locations
Brentuximab Vedotin and Nivolumab with or without Ipilimumab in Treating Patients with Relapsed or Refractory Hodgkin Lymphoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 347 locations
Nivolumab in Treating Patients with Localized Kidney Cancer Undergoing Nephrectomy
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 250 locations
Axitinib and Nivolumab in Treating Participants with Unresectable or Metastatic TFE / Translocation Renal Cell Carcinoma
Status: Active
Age: 1 year and over
Gender: Male or Female
Location: 181 locations
Cabozantinib and Nivolumab in Treating Patients with Advanced, Recurrent or Metastatic Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 33 locations
1 2 3 ... 35 Next >